Alberto Fernández Jaén-rekin lankidetzan egindako argitalpenak (4)

2018

  1. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis

    BMC Psychiatry, Vol. 18, Núm. 1

2014

  1. Expert Recommendation: Contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)

    Actas Espanolas de Psiquiatria, Vol. 42, pp. 1-16

2013

  1. Evaluating Internet information on attention-deficit/hyperactivity disorder (ADHD) treatment: parent and expert perspectives.

    Education for health (Abingdon, England), Vol. 26, Núm. 1, pp. 48-53

  2. Evaluating internet information on attention- deficit/hyperactivity disorder (ADHD) treatment: Parent and expert perspectives

    Education for Health: Change in Learning and Practice, Vol. 26, Núm. 1, pp. 48-53